These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. RYR1-related central core myopathy in a Chinese adolescent boy. Chan B; Chen SP; Wong WC; Mak CM; Wong S; Chan KY; Chan AY Hong Kong Med J; 2011 Feb; 17(1):67-70. PubMed ID: 21282829 [TBL] [Abstract][Full Text] [Related]
4. Clinical and histopathological aspects of central core disease associated and non-associated with RYR1 locus. Romero NB; Herasse M; Monnier N; Leroy JP; Fischer D; Ferreiro A; Viollet L; Eymard B; Laforêt P; Monges S; Lubieniecki F; Taratuto AL; Guicheney P; Lunardi J; Fardeau M Acta Myol; 2005 Oct; 24(2):70-3. PubMed ID: 16550918 [TBL] [Abstract][Full Text] [Related]
5. Dominant and recessive RYR1 mutations in adults with core lesions and mild muscle symptoms. Duarte ST; Oliveira J; Santos R; Pereira P; Barroso C; Conceição I; Evangelista T Muscle Nerve; 2011 Jul; 44(1):102-8. PubMed ID: 21674524 [TBL] [Abstract][Full Text] [Related]
6. Pathologic quiz case: a slow and awkward child. Central core disease. Giampetro DM; Prayson RA; Friedman NR; Staugaitis SM Arch Pathol Lab Med; 2004 Apr; 128(4):481-2. PubMed ID: 15043482 [No Abstract] [Full Text] [Related]
7. Asymmetric Muscle Involvement in an Indian Family With Central Core Myopathy. Adam RK; Kasinathan A; Sankhyan N; Singhi P J Clin Neuromuscul Dis; 2018 Mar; 19(3):142-143. PubMed ID: 29465616 [No Abstract] [Full Text] [Related]
8. Functional properties of RYR1 mutations identified in Swedish patients with malignant hyperthermia and central core disease. Vukcevic M; Broman M; Islander G; Bodelsson M; Ranklev-Twetman E; Müller CR; Treves S Anesth Analg; 2010 Jul; 111(1):185-90. PubMed ID: 20142353 [TBL] [Abstract][Full Text] [Related]
9. Ryanodine receptor mutations in malignant hyperthermia and central core disease. McCarthy TV; Quane KA; Lynch PJ Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202 [TBL] [Abstract][Full Text] [Related]
10. RYR1 mutations in UK central core disease patients: more than just the C-terminal transmembrane region of the RYR1 gene. Shepherd S; Ellis F; Halsall J; Hopkins P; Robinson R J Med Genet; 2004 Mar; 41(3):e33. PubMed ID: 14985404 [No Abstract] [Full Text] [Related]
12. Central core disease: new findings in an old disease. Muntoni F; Sewry CA Brain; 2003 Nov; 126(Pt 11):2339-40. PubMed ID: 14561637 [No Abstract] [Full Text] [Related]
14. Clinical features and ryanodine receptor type 1 gene mutation analysis in a Chinese family with central core disease. Chang X; Jin Y; Zhao H; Huang Q; Wang J; Yuan Y; Han Y; Qin J J Child Neurol; 2013 Mar; 28(3):384-8. PubMed ID: 22550088 [TBL] [Abstract][Full Text] [Related]
15. Familial RYR 1 mutation associated with mild and severe central core disease. Erendzhinova E; Robinson CA; Lowry NJ; Lemire EG Can J Neurol Sci; 2010 Jul; 37(4):528-31. PubMed ID: 20724266 [No Abstract] [Full Text] [Related]
16. Multiminicore myopathy, central core disease, malignant hyperthermia susceptibility, and RYR1 mutations: one disease with many faces? Mathews KD; Moore SA Arch Neurol; 2004 Jan; 61(1):27-9. PubMed ID: 14732615 [No Abstract] [Full Text] [Related]
17. A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene. Ferreiro A; Monnier N; Romero NB; Leroy JP; Bönnemann C; Haenggeli CA; Straub V; Voss WD; Nivoche Y; Jungbluth H; Lemainque A; Voit T; Lunardi J; Fardeau M; Guicheney P Ann Neurol; 2002 Jun; 51(6):750-9. PubMed ID: 12112081 [TBL] [Abstract][Full Text] [Related]